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Abstract 27 
 28 
A robust redox extraction protocol for quantitative and reproducible metabolite isolation and 29 
recovery has been developed for simultaneous measurement of nicotinamide adenine 30 
dinucleotide (NAD) and its reduced form, NADH, from Saccharomyces cerevisiae. Following 31 
culture in liquid media, approximately 108 yeast cells were harvested by centrifugation and then 32 
lysed under non-oxidizing conditions by bead blasting in ice-cold, nitrogen-saturated 50-mM 33 
ammonium acetate. To enable protein denaturation, ice cold nitrogen-saturated CH3CN + 50-mM 34 
ammonium acetate (3:1; v:v) was added to the cell lysates. After sample centrifugation to pellet 35 
precipitated proteins, organic solvent removal was performed on supernatants by chloroform 36 
extraction. The remaining aqueous phase was dried and resuspended in 50-mM ammonium 37 
acetate. NAD and NADH were separated by HPLC and quantified using UV-VIS absorbance 38 
detection. Applicability of this procedure for quantifying NAD and NADH levels was evaluated 39 
by culturing yeast under normal (2% glucose) and calorie restricted (0.5% glucose) conditions. 40 
NAD and NADH contents are similar to previously reported levels in yeast obtained using 41 
enzymatic assays performed separately on acid (for NAD) and alkali (for NADH) extracts. 42 
Results demonstrate that it is possible to perform a single preparation to reliably and robustly 43 
quantitate both NAD and NADH contents in the same sample. Robustness of the protocol 44 
suggests it will be 1) applicable to quantification of these metabolites in mammalian and 45 
bacterial cell cultures; and 2) amenable to isotope labeling strategies to determine the relative 46 
contribution of specific metabolic pathways to total NAD and NADH levels in cell cultures. 47 
48 
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Introduction 48 
 49 
Nicotinamide adenine dinucleotides are ubiquitous biological molecules that participate 50 
in many metabolic reactions. Recent studies indicate that these dinucleotides may play important 51 
roles in transcriptional regulation,1,2 calorie restriction mediated lifespan extension,3-5 and age-52 
associated diseases.6-8 However, current methods for the quantitation of nicotinamide adenine 53 
dinucleotides can be complicated by the oxidation of reduced species. Most studies have relied 54 
on separate extractions for nicotinamide adenine dinucleotide (NAD) and NADH determinations: 55 
a basic extraction for the reduced species and a separate acidic extraction for the oxidized 56 
species.3,9-12 The extraction conditions are specific for the stabilization of either oxidized 57 
compounds, which are more stable in acid, or reduced compounds, which are more stable in 58 
base. Metabolites in the separate extracts are then commonly quantitated by enzymatic cycling 59 
assays3,9-12 that amplify a compound of interest through a series of cycling steps involving 60 
coupled reactions with final quantitation achieved flourimetrically. While enzymatic cycling 61 
assays can quantitate the total amount of pyridine dinucleotides, they cannot be used to assess 62 
specific metabolic pathways using isotopically-labeled and unlabeled forms of a compound. 63 
NAD and NADH measurements in yeast (Saccharomyces cerevisiae) indicate that levels 64 
of these metabolites may play important roles in lifespan extension.10 Yeast have frequently been 65 
used as a model organism to study calorie restriction (CR) where lifespan extension can be 66 
achieved by reducing the glucose concentration in the growth media from 2% to 0.5%.3-5 The 67 
benefit of CR appears to require Sir2, a sirtuin family protein that exhibits an NAD-dependent 68 
deacetylase activity and whose function, in part, includes regulation of chromatin silencing, 69 
genomic stability at the ribosomal DNA loci.5 NADH may regulate longevity by inhibiting the 70 
activity of Sir2.10  71 
NAD is synthesized via two major mechanisms in yeast, the de novo and salvage 72 
pathways. 1-3,13,14 In the de novo pathway, NAD is synthesized from tryptophan present within 73 
the cell. In the salvage pathway, NAD is generated from the recycling of degraded NAD 74 
products, such as nicotinamide, and through the incorporation of nicotinic acid from the 75 
extracellular environment. Both pathways play redundant yet essential roles in cell growth, but 76 
the salvage pathway is thought to play a more important role in life span regulation.4,13 To 77 
elucidate this role, it is important to determine the relative contributions of the salvage and de 78 
novo pathways to the total amount of cellular NAD and NADH. Culturing yeast in media 79 
containing isotopically-labeled nicotinic acid will enable approaches for quantitating levels of 80 
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metabolites derived from the salvage pathway.15 In conjunction with measurements of total 81 
cellular NAD and NADH, isotopic measurements should afford estimates of NAD and NADH 82 
contents from the de novo pathway. However, an extraction and isolation method that enables 83 
quantitation of both labeled and unlabelled forms of NAD and NADH is required before such 84 
quantitative assessments are feasible. 85 
High performance liquid chromatography (HPLC) is well suited for separating and 86 
quantitating metabolites and can be used to isolate isotopically-labeled molecules in biological 87 
samples.16 A handful of single sample extraction protocols have been developed using HPLC 88 
separation to quantitate nicotinamide adenine dinucleotides within the same sample.17-19 Some of 89 
these techniques rely on acid extraction protocols and HPLC peak integration to measure NAD 90 
directly and indirectly measure NADH by its acid degraded products.19 Another procedure 91 
involves a rapid post-extraction labeling reaction with cyanide in basic solution that leads to the 92 
reaction product NAD-CN for NAD.17 NADH and the derivitized NAD-CN isomers are then 93 
quantified via fluorescence detection.  94 
Here, we report the development of a single sample extraction and HPLC processing 95 
procedure that enables the isolation and quantitation of total cellular NAD and NADH from 96 
pools of yeast. The protocol avoids derivitization or the measurement of degradation products 97 
from NAD or NADH making this approach amenable to isotope labeling strategies as the 98 
potential for loss of an isotope label is minimized. Metabolite recovery and stability, as well as 99 
reproducibility of the whole procedure are examined. Applicability of this procedure to quantify 100 
NAD and NADH levels in yeast is evaluated by culturing yeast under normal (2% glucose) and 101 
calorie restricted (0.5 % glucose) conditions. 102 
 103 
104 
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Methods 104 
 105 
Yeast culture.  106 
Saccharomyces cerevisiae (BY4742) were cultured in 25-ml volumes of liquid synthetic 107 
complete media at 30oC consisting of 6.7 g/L Bacto yeast nitrogen base without amino acids 108 
(Becton-Dickinson, Franklin Lakes, NJ), 1.92 g/L yeast synthetic drop-out media supplement 109 
without uracil (Sigma-Aldrich, St Louis, Mo), 0.08 g/L uracil (Sigma-Aldrich, St Louis, Mo) and 110 
20 g/L glucose (anhydrous dextrose) (EMD Chemicals, Gibbstown, NJ) dissolved in distilled 111 
H2O. Media was filter sterilized (0.22-µm GP Express Plus Membrane, Millipore, Billerica, MA) 112 
before use as previously described20. For calorie restriction, 5 g/L instead of 20 g/L glucose was 113 
used. Around 104 yeast were used to inoculate each culture. 100-µl aliquots were periodically 114 
taken from culture for growth and cell density measurement via hemacytometer. Cultures were 115 
maintained until they contained ~ 7 x 106 cells/ml corresponding to mid-log phase growth. 116 
 117 
Preparation of yeast pellets for metabolite extraction.  118 
Approximately 7 x 107 yeast were harvested by aliquoting 10 ml of the culture into a 15 ml 119 
Falcon tube (Becton-Dickinson, Franklin Lakes, NJ) followed by centrifugation for 3 minutes at 120 
4,000 rpm at 4°C in a Sorvall RC 5C Plus (DuPont, Newtown CT). The supernatant was 121 
discarded and the pellet resuspended in 1-ml PBS at 4oC, and transferred to a 2-ml polypropylene 122 
bead blasting tube (Outpatient Services, Petaluma, CA). The walls of the Falcon tube were 123 
washed with 1-ml ice-cold PBS and the rinsate added to the bead blasting tube. Samples were 124 
centrifuged at 4,000 rpm for 3 minutes in a bench top mini-centrifuge (National Labnet, 125 
Woodbridge NJ) at 4°C and the supernatant discarded. 126 
 127 
Single sample metabolite extraction for HPLC speciation. 128 
Using the work of Lazzarino et al.18 as a conceptual basis, an extraction protocol was developed 129 
to recover water-soluble metabolites from yeast cells for fractionation by HPLC. 600 µl of 50-130 
mM ammonium acetate (Aldrich, Milwaukee, WI) saturated with N2 gas was added to the 131 
pelleted yeast in bead blasting tubes and the tubes filled to the meniscus with 212-300 µm 132 
diameter acid-washed glass beads (Sigma-Aldrich, St Louis, Mo). Yeast were bead blasted at 133 
maximum speed using a Mini-Beadbeater™ (BioSpec Products, Bartlesville, OK) for 30 seconds 134 
followed by a 2-minute incubation on ice and another 30 seconds of bead blasting. The bead 135 
 6 
blasting tube was then inverted and its base lanced with a red-hot 0.5 inch long 26-gauge needle 136 
(Becton Dickinson & Co, Franklin Lakes NJ). An open-ended 1.5 ml-microfuge tube 137 
(Eppendorf, Westbury NY) was placed over the base of bead blasting tube and the assembly 138 
nested upright in a 50-ml Falcon tube (Becton-Dickinson, Franklin Lakes, NJ). The nested tubes 139 
were centrifuged at 2000 rpm for 3 minutes in a Sorvall centrifuge to separate cell lysates from 140 
glass beads. Cell lysates were then transferred to a cold 2 ml microfuge tube (Eppendorf, 141 
Westbury NY) and kept on ice. The glass beads in the bead blasting tube were then washed twice 142 
with 600 µl of a N2-saturated solution of acetonitrile (Sigma-Aldrich, St Louis, Mo) and 50-mM 143 
ammonium acetate (3:1; v:v) vortexed and centrifuged for 3 minutes at 2000 rpm at 4°C. After 144 
each wash, the rinsate was transferred to the microfuge tube containing the cell lysate.  145 
 Following washing, cell lysates were centrifuged at 10,000 rpm for 1 minute at 4°C. The 146 
supernatant was transferred to a 10-ml glass test tube (Corning Inc., Corning NY) and stored on 147 
ice. The remaining pellet was resuspended in 600 µl of a N2-saturated solution consisting of 148 
acetonitrile and 50-mM ammonium acetate (3:1; v:v) and centrifuged at 10,000 rpm for 5 149 
minutes at 4°C. The resulting supernatant was pooled with the previous supernatant and the 150 
remaining pellet discarded. Lipids were extracted from the liquid volume using 10 ml of ice-cold 151 
chloroform (VWR International, West Chester, PA) and 5 seconds vigorous agitation. Samples 152 
were left to separate on ice for 30 minutes. The upper aqueous phase was collected in a 15-ml 153 
Falcon tube and was quickly frozen at -80°C and lyophilized for 15 hours in a Christ Alpha 1-2 154 
freeze dryer (Martin Christ GmbH, Germany) while the organic phase was discarded. To test 155 
whether discarded protein pellets contained NAD or NADH, randomly selected pellets were 156 
resuspended in 600 µl of chloroform using vigorous agitation, dried under a stream of nitrogen, 157 
resuspended in 600 µl of acetonitrile, and stored in a 4°C refrigerator overnight. The lysate was 158 
then vortexed vigourously for 30 seconds and centrifuged at 10,000 rpm for 5 minutes at 4°C. 159 
The supernatant was frozen at -80°C and then lyophilized for at least 15 hours. 160 
Lyophilized samples were resuspended in 250 µl ice-cold 50-mM ammonium acetate and 161 
vortexed vigourously. The suspension was filtered with a 0.45-µm polyvinylidene fluoride 162 
micro-spin filter tube (Alltech Associates Inc., Deerfield, IL) using a bench top mini-centrifuge 163 
operating at 10,000 rpm for 1 minute and aliquots analyzed by HPLC.  164 
 165 
HPLC speciation of metabolites. 166 
HPLC measurements were performed using a Hydrosphere C18 column (5 micron, 150 x 4.6 167 
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mm I.D. (Waters, Milford MA)) with a direct connection UNIGUARD guard column (Thermo 168 
Electron, Newington, NH) fitted with the appropriate PEEK tip and Hypersil Gold guard 169 
cartridge (5 micron, 10 x 4.0 mm I.D., (Thermo Electron, Newington, NH)) on an Agilent 1100 170 
HPLC (Hewlett-Packard Wilmington, DE). The C18 column and guard column were maintained 171 
at room temperature (22oC). Up to 100-µl aliquots of metabolites were injected and fractionated 172 
by reversed-phase chromatography. A 1 ml/min gradient of mobile phase A (50-mM ammonium 173 
acetate) and mobile phase B (100% acetonitrile) initially consisting of 100% mobile phase A, 174 
with mobile phase B increasing to 5% over 30 minutes at a rate of 0.1% per minute was utilized. 175 
The column was washed after each separation by increasing mobile phase B to 90% for 7 176 
minutes. UV absorbance was monitored at 260 nm and 340 nm and pertinent peak areas 177 
integrated using area under the curve algorithms. Quantitation of NAD was assessed using 178 
absorbance at 260 nm. Since NADH absorbs at 340 nm whereas NAD does not, quantitation of 179 
NADH was assessed using absorbance at both 260 and 340 nm. 180 
Peak identification and quantitation of NAD and NADH were assessed using standard 181 
solutions of NAD and NADH (Sigma-Aldrich, St Louis, MO) dissolved in 50-mM ammonium 182 
acetate. Standard stock solutions were prepared fresh every week, while working standard 183 
solutions were prepared daily by appropriate dilution of the stock solutions. Working standards 184 
were always analyzed on the same day as samples of interest to generate standardization curves.  185 
 Metabolite contents were calculated from the measured absorbance, corrected for 186 
recovery efficiency and processing volumes and, when relevant, converted to units of amol/cell 187 
using the number of cells in the extraction and the molecular weight of the metabolite of interest.  188 
 189 
Mass spectrometry measurements. 190 
Fractions obtained via HPLC analysis of standards or metabolite extracts from yeast were dried 191 
in a centrifugal vacuum evaporator (Jouan, Winchester, VA) at ambient temperature and stored 192 
at –80oC prior to mass spectrometry (MS) analysis. Samples were resuspended in a 89.9:10:0.1 193 
water/acetonitrile/formic acid (Sigma-Aldrich, St Louis, Mo) solution prior to direct infusion 194 
into the MS system by a syringe pump without a column at a flow rate of 10 ml/min. 195 
Electrospray ionization (ESI)-MS analyses were carried out using a Quattro MicroTM API 196 
(Micromass UK, Manchester, UK) mass spectrometer. High-resolution MS (HR/MS) analyses 197 
were done in ESI mode on a Micromass Fourier transform MS (Micromass UK Manchester, 198 
UK). All ESI-MS spectra were obtained in positive ion mode with an electrospray capillary 199 
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potential of 3.0 kV and a cone potential of 21 V. Standard solutions of NAD and NADH, 200 
resuspended in a 89.9:10:0.1 water/acetonitrile/formic acid mixture, were used for NAD and 201 
NADH identification in the mass spectrometry measurements. 202 
 203 
Reproducibility, linearity and sensitivity provided by the chromatographic method. 204 
Reproducibility, linearity and sensitivity provided by the chromatographic method were studied 205 
with solutions containing up to 1µg/µl NAD or NADH standards with HPLC injection volumes 206 
varying between 5 and 100 µl. The quantities of NAD and NADH used in the linearity 207 
experiments spanned the working range of metabolite contents obtained from processing pools of 208 
yeast. Regression analysis was utilized to determine linear correlation coefficients of standard 209 
curves for each standard. Limits of detection (LOD) were considered to be the quantities that 210 
produced a peak whose area was three times that of the square root of the integrated background 211 
underneath the peak. Reproducibility of the chromatographic method was evaluated using up to 212 
100-µl injections of standard solutions on the same day (intra-day) and on various days (inter-213 
day) over a three-month period. Fresh standard solutions were prepared weekly for the inter-day 214 
reproducibility measurements. 215 
 216 
Recovery and reproducibility of the extraction protocol.  217 
Recovery efficiency of the extraction protocol was determined with standard solutions 218 
containing 2.5 µg of either NAD or NADH dissolved in 50-mM ammonium acetate. For standard 219 
addition experiments yeast cultures were split into two samples prior to bead beating. One 220 
sample was processed as previously described to determine yeast NAD and NADH contents. 221 
Standard solutions containing 2.5 µg or 10 µg of either NAD or NADH (these amounts span the 222 
range of NAD and NADH contents within yeast metabolite extracts) dissolved in 50-mM 223 
ammonium acetate were added to bead beaten cell lysates from the other sample for subsequent 224 
processing. Total quantities of NADH and NAD in spiked samples were corrected for the 225 
contribution of yeast metabolites and recovery of NAD and NADH from the spikes assessed.  226 
 227 
Statistical analysis. 228 
Differences in NAD and NADH contents of yeast grown in 20 g/L or 5 g/L glucose were 229 
assessed by unpaired two-tailed Student’s t-tests. A significance level of less than 0.02 was 230 
considered meaningful. A significance level between 0.02 and 0.10 was considered evidence of a 231 
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possible trend, while a significance level of greater than 0.10 was considered to indicate no 232 
significant difference. 233 
234 
 10 
Results 234 
 235 
Reproducibility, linearity and sensitivity provided by the chromatographic method. 236 
Typical chromatograms of standard solutions containing NAD and NADH are shown in 237 
Figure 1. Intra-day variability observed in retention time of each authentic compound was 238 
typically less than 2 percent of the mean retention time. Inter-day variability observed in 239 
retention times of the authentic compounds was typically less than 60 seconds. Linearity for peak 240 
area quantitation at 260-nm absorbance of standard solutions of NAD and NADH is shown in 241 
Figure 2. Linearity for peak area quantitation at 340-nm absorbance of standard solutions of 242 
NADH (data not shown) was virtually identical to that observed for NADH in Figure 2. Limits 243 
of detection (LOD) at 260-nm absorbance were 10 ng for NAD and 25 ng for NADH, while the 244 
limit of detection at 340-nm absorbance was 20 ng for NADH. Linearity and LOD for the 245 
chromatographic method were insensitive to the range of injection volumes (5 to 100 µl) utilized 246 
for each standard. Table 1 summarizes the intra-day and inter-day precision of the 247 
chromatographic method for the detection of NAD and NADH at 260-nm absorbance. The intra-248 
day and inter-day precision of the chromatographic method for the detection of NADH at 340-249 
nm absorbance was virtually identical to that shown for NADH in Table 1 (data not shown). 250 
Relative standard deviations (standard deviation expressed as a percentage of the corresponding 251 
mean value) for detection of the authentic compounds ranged from 1.6 to 2.3% for the intra-day 252 
reproducibility experiments and 3.3 to 4.0% for the inter-day reproducibility experiments.  253 
 254 
Recovery and reproducibility of the metabolite extraction protocol. 255 
Table 2 shows recoveries of NAD and NADH obtained with our extraction and 256 
speciation protocol for standard solutions containing 2.5-µg of either NAD or NADH. 257 
Differences in measured NADH values via absorbance at 340-nm and 260-nm in the recovery 258 
experiments for standard solutions were typically less than 1%. Recovery of NAD was 95.9 +/- 259 
4.9% (mean +/- standard deviation) while no detectable conversion or degradation of NAD to 260 
other metabolites was observed. Recovery of NADH was 83.4 +/- 6.6 % with 12.9 +/- 6.2 % of 261 
the NADH oxidized to NAD during sample processing.  262 
Table 3 shows recoveries of NAD and NADH obtained from the standard addition 263 
experiments performed on yeast cultures grown in 20 g/L glucose after correction for the 264 
contribution from yeast to the NAD and NADH contents. Differences in measured NADH values 265 
 11 
via absorbance at 340-nm and 260-nm in the standard addition experiments were typically less 266 
than 1%. Recoveries from the standard addition experiments are consistent with the metabolite 267 
recovery efficiency data shown in Table 2. Recovery of 2.5 µg NAD matrix spikes was  95.6 +/- 268 
8.2%, while recovery of 10 µg NAD matrix spikes was 96.5 +/- 6.0 %. No detectable conversion 269 
or degradation of NAD matrix spikes to other metabolites was observed. Recovery of 2.5 µg 270 
NADH matrix spikes was 82.6 +/- 12.3%, while recovery of 10 µg NADH matrix spikes was 271 
83.2 +/- 9.9%. 13.3 +/- 11.3% of the 2.5 µg NADH matrix spikes oxidized to NAD during 272 
sample processing, while 12.0 +/- 8.0% of the 10 µg NADH matrix spikes oxidized to NAD. 273 
Standard addition experiments performed on yeast cultures grown in 5 g/L glucose produced 274 
similar matrix spike recoveries (data not shown) to those reported in Table 3.  275 
 276 
Measurement of NAD and NADH contents in yeast. 277 
Figure 3 shows a typical HPLC chromatogram of metabolites extracted from approximately 7 x 278 
107 yeast grown in 20 g/L glucose. HPLC chromatograms of metabolites extracted from yeast 279 
grown in 5 g/L glucose were qualitatively similar to that shown in Figure 3. Fractions of yeast 280 
metabolite extracts with retention times corresponding to those of authentic NAD and NADH 281 
standards were collected and their identity confirmed with mass spectrometry. Mass 282 
spectrometry data from these metabolite fractions was highly consistent with mass spectrometry 283 
data obtained from corresponding authentic standards of NAD and NADH. Briefly, mass 284 
spectrometry of metabolite fractions with retention times corresponding to that of the authentic 285 
NAD standard revealed a peak corresponding to a M/Z of 664.1 +/- 0.3 (expected 664.4 for 286 
M+H) and a pattern of fragmentation ions that was similar to that of the authentic standard (data 287 
not shown).  Likewise, mass spectrometry of metabolite fractions with retention times 288 
corresponding to that of the authentic NADH standard revealed a peak corresponding to a M/Z 289 
of 666.1+/-0.3 (expected 666.4 for M) and a pattern of fragmentation ions of smaller M/Z that 290 
was similar to that of the authentic standard (data not shown). 291 
Metabolite extracts from yeast cultured in 20 g/L glucose typically contained 4 µg each 292 
of NAD and NADH, while those cultured in 5 g/L glucose contained 5 µg of NAD and 2.5 µg 293 
NADH. Differences in measured NADH values via absorbance at 340-nm and 260-nm for the 294 
metabolite extracts were typically less than 1%. Figure 4 and the top row in Table 4 shows 295 
contents (amol/cell) of NAD and NADH in yeast grown in synthetic complete media containing 296 
20 g/L glucose or 5 g/L glucose. HPLC analysis of extracts from the remaining protein pellet 297 
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revealed no detectable NAD or NADH (data not shown). For growth in 20 g/L glucose (non-298 
calorie restriction), NAD is present in yeast cells at 97 +/- 13 amol/cell. This value increases 299 
significantly (P < 0.02) to 122 +/- 19 amol/cell when cells are cultured in 5 g/L glucose (calorie 300 
restriction. NADH values, however, significantly decrease (P < 0.02) from 99 +/- 13 amol/cell 301 
under non-calorie restricted conditions to 63 +/- 10 amol/cell with calorie restriction. The sum of 302 
NAD and NADH is not significantly different for both growth conditions at approximately 190 303 
amol/cell. The ratio of NAD to NADH increases significantly (p < 0.02) from 1.0 for yeast 304 
cultured in 20 g/L glucose to 1.9 for yeast cultured in 5 g/L glucose. 305 
 306 
 307 
308 
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Discussion 308 
 309 
Minimization of artifactual oxidation of reduced metabolite species is challenging to achieve for 310 
any metabolite extraction protocol. Here, we have improved on previous approaches and 311 
developed a method for measuring NAD and NADH in the same sample of yeast using a simple 312 
extraction protocol. Reverse phase HPLC provided excellent speciation and resolution of NAD 313 
and NADH from other metabolites within a 25-minute runtime. The dynamic range of the 314 
chromatographic method was shown to be linear for the 38 ng to 18.3 µg quantities of the 315 
authentic NAD standard studied and 68 ng to 13.9 µg quantities of the authentic NADH standard 316 
studied. Meanwhile, metabolite extracts from ~ 7x 107 yeast cultured in 20 g/L glucose contained 317 
approximately 4 µg each of NAD and NADH, while yeast cultured in 5 g/L glucose contained 318 
approximately 5 µg of NAD and approximately 2.5 µg NADH. Consequently, the quantities of 319 
authentic standards of NAD and NADH used in studying the linearity of the chromatographic 320 
method correspond to NAD and NADH contents that one could expect to extract from ~ 2 x 106 321 
to ~ 2 x108 yeast. The sensitivity of the chromatographic method for NAD (10 ng) and NADH 322 
(20 ng) detection compares favorably with that of other chromatographic methods17 and suggest 323 
that NAD contents from as few as  2 x 105 yeast cells and NADH contents from as few as 5 x 105 324 
yeast cells could be quantified. However, such cell numbers are at least as high those used for 325 
enzymatic cycling measurements of NAD and NADH in yeast which are routinely performed on 326 
105.10 The chromatographic method produces acceptable intra-day and inter-day reproducibility 327 
in retention time, speciation and subsequent quantitation of NAD and NADH. The higher inter-328 
day variation observed for quantitation of the authentic compounds plausibly arises as the intra-329 
day measurements were performed on the same set of standard solutions while fresh solutions 330 
were prepared weekly for the inter-day measurements.  The higher inter-day than intra-day 331 
variation observed for retention time of the authentic compounds plausibly arises as day to day 332 
variations in pump and column performance are likely greater than variation within a single day.   333 
Measurements performed with authentic standards of NAD and NADH reveal that the 334 
extraction protocol typically produces at least 95 % recovery of NAD and at least 80 % recovery 335 
of NADH. No degradation products of the NAD standard were detectable while NADH 336 
oxidation to NAD appears to be approximately 13%. However, great care must be exercised at 337 
all points in the extraction protocol to prevent artifactual oxidation or degradation of NADH. 338 
Precautions were taken at each step in the metabolite extraction protocol to minimize processing 339 
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time and sample temperature to minimize NADH oxidation while optimizing metabolite 340 
recovery. We found that samples must be kept as cold as possible. Allowing the sample 341 
temperature to supersede room temperature can cause oxidation of NADH to occur by as much 342 
as 50%. Accordingly, yeast were bead blasted for two 30-second periods and left on ice for the 343 
intervening period because greater consistency in NADH recovery was obtained over that from 344 
bead blasting for one 60-second period. Frozen extracts may be kept in a -80°C freezer; however 345 
standard solutions containing NADH frozen for more than 72 hours started to display signs of 346 
NADH oxidation.  347 
We also found that multiple washings of the glass beads in the bead blasting tubes 348 
following bead beating, careful attention to vigorous vortexing and agitation during resuspension 349 
or mixing activities, and conservative centrifugation times could improve metabolite recoveries 350 
by as much as 20%. Interestingly, we found that lipid extraction using chloroform resulted in 351 
lower recoveries of NADH if the organic and upper aqueous phases were left to separate on ice 352 
for less than 15 minutes. NADH recoveries reached a stable plateau for separation times of 25 353 
minutes or more. Because we observed that lyophilization of standard solutions of NADH in 50-354 
mM ammonium acetate can result in oxidation of NADH to NAD, the longer settling times 355 
during lipid extraction possibly allow ammonium acetate in the metabolite extracts to partition 356 
into the organic phase.  357 
NAD and NADH levels in yeast determined in the current study are compared with those 358 
obtained in prior studies via enzymatic assay in Table 4. Total NAD values for normal growth 359 
conditions (i.e., 20 g/L glucose) have been reported between 79.8 and 210 amol/cell,3,9-12 which 360 
is consistent with our findings of 97 +/- 13  amol/cell. There are few published reports of 361 
measured NADH values in yeast presumably because of the difficulty in making measurements 362 
on such readily oxidizable molecules. NADH values obtained from the current method are nearly 363 
40% higher than those obtained through enzymatic cycling assays.3,10 Cells grown under calorie 364 
restriction (i.e., 5 g/L glucose) have been reported to contain a similar range of NAD values as 365 
cells grown without calorie restriction.3,10 We measured 122 +/- 19 amol/cell using the current 366 
method, which falls well within the published range. NADH values obtained from yeast grown 367 
under calorie restriction have been reported at 27 amol/cell.9 Using the current method for 368 
metabolite extraction, we obtain 63 +/- 10 amol/cell of NADH from calorie-restricted cells. 369 
However, similar to the study of Lin et al.,9 we found that under calorie restriction conditions, 370 
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NADH contents are significantly reduced and that the NAD/NADH ratio significantly increases 371 
compared to yeast cultured in 20 g/L glucose. 372 
Enzymatic cycling reactions for indirectly measuring NAD and NADH typically rely on a 373 
heating step under either acidic or alkali conditions for cell lysis and preservation of either NAD 374 
(acidic) or NADH (alkali) 3,9-12 and there can be a large loss (more than half) of the metabolite of 375 
interest during the harsh extractions conditions. Interestingly, during development of our assay, 376 
we observed that the choice of buffer the yeast are maintained in prior to, and during bead 377 
beating, had a profound influence on intracellular NAD and NADH contents. Compared to bead 378 
beating in 50 mM ammonium acetate, bead beating yeast in an acetonitrile: 10-mM KH2PO4 379 
buffer (3:1 v:v) resulted in reduction of cellular NADH levels by as much as 90%, while bead 380 
beating yeast in a 50-mM KH2PO4 buffer resulted in reduction of cellular NADH levels by as 381 
much as 20%. Stored NADH has been shown in various animal models to be rapidly utilized by 382 
cells under stressful conditions, including oxidative stress21 and high osmolarity22, while NADH 383 
has been shown to degrade more rapidly in KH2PO4 buffers than other buffers such as Pipes.23 It 384 
is plausible that the lower NADH levels observed in the enzymatic assays and by bead beating in 385 
acetonitrile are a result of a cellular stress response to the buffer. These observations suggest that 386 
it is crucial that exposure of intact cells to chemical or environmental stressors prior to, and 387 
during, cell lysis be minimized. 388 
The work of Lazzarino et al.18 served as a conceptual basis for the development of the 389 
metabolite extraction protocols reported here. Their work was developed for recovering a broad 390 
range of metabolites representative of both the redox and energy states of cells in animal tissue 391 
and utilized acetonitrile and KH2PO4 containing buffers during both cell lysis and metabolite 392 
extraction18.  To enable robust, reliable measurement of NAD and NADH in yeast, it was 393 
necessary to develop significantly different cell lysis and metabolite extraction methods. 394 
Acetonitrile-containing buffers were avoided during cell lysis and KH2PO4-containing buffers 395 
were avoided throughout the protocol. Owing to their robust cell wall bead-beating procedures 396 
were used to rapidly and efficiently lyse yeast.  We also found that multiple chloroform 397 
extraction steps proposed by Lazzarino et al.18 did not increase the yields of NAD and NADH 398 
recovered from yeast. Elimination of such steps reduced total sample processing time by at least 399 
twelve hours. The extraction method reported here relies on rapid and efficient cell lysis and 400 
relatively benign chemical conditions prior to lysis and during metabolite extraction. These 401 
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careful considerations likely minimize cellular use and degradation of NADH resulting in 402 
recovery of higher amounts of NADH. 403 
 The protocol reported here measures the total amount (i.e., free + bound) of NAD and 404 
NADH in yeast. Ratios of total NAD to total NADH in yeast seem to be within a reasonable 405 
range for NAD regulation.24 However, baseline ratios of the free pool of NAD:NADH have been 406 
debated.25-29 The free pool NAD:NADH ratio has been estimated from concentrations of the 407 
intracellular metabolites, pyruvate and lactate, for various tissues in different species animal 408 
species to range from 0.1 to 10.25-29 During development of the assay reported here, we found that 409 
yeast cell lysates that were passed through a 0.45-µm glass fiber filter, immediately after bead 410 
beating and prior to metabolite extraction, possessed NADH levels that were around one sixth of 411 
those obtained from extractions of unfiltered lysates (data not shown). NAD levels, however, 412 
were not altered resulting in NAD/NADH ratios of approximately 7. This observation of filtered 413 
NAD and NADH levels is consistent with the hypothesis that the majority of cellular NADH is 414 
likely membrane or protein bound, while the majority of NAD is not protein bound. In our 415 
protocol, bound NADH is likely effectively released from proteins after bead beating by the use 416 
of acetonitrile which is well-known for its ability to denature proteins.30 417 
 Results of this study and that of others10 reveal that yeast NADH contents are 418 
significantly reduced under calorie restricted conditions while NAD:NADH ratios increase. It 419 
has been suggested that this shift may lead to an activation of Sir2, a sirtuin protein family 420 
member.4 NADH functions as an inhibitor of Sir2,10 so lower levels of NADH found in yeast 421 
cells grown under calorie restriction could result in less inhibition of Sir2 and therefore an 422 
increased life span in yeast.10 By culturing yeast in 14C-labeled growth media, we are 423 
investigating the relative contributions of the de novo and salvage pathways to total NAD and 424 
NADH levels in yeast strains as a function of nutrient status.31 The protocol developed here 425 
avoids derivitization or the measurement of degradation products from NAD or NADH so that 426 
the potential for loss of the isotope label is minimized. Initial radiolabeling of yeast cells and 427 
subsequent accelerator mass spectrometry (AMS) measurement for 14C quantitation indicate that: 428 
1) yeast cells are amenable to such labeling and quantification;31 and 2) the single sample 429 
extraction and HPLC speciation protocol developed here is amenable to AMS quantatiation of 430 
14C in isolated fractions of the HPLC trace31 enabling us to quantify both total (by UV-Vis 431 
absorption) and 14C labeled NAD and NADH (by AMS) from the same sample.  432 
 433 
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Tables 443 
 444 
 445 
 NAD NADH 
Amount (µg) 0.125 0.125 
Intra-day precision (% relative standard deviation) (n=3) 2.0 2.3 
Inter-day precision (% relative standard deviation) (n=5) 3.9 4.0 
Amount (µg) 0.625 0.375 
Intra-day precision (% relative standard deviation) (n=4) 1.6 1.9 
Inter-day precision (% relative standard deviation) (n=5) 4.0 3.6 
Amount (µg) 5.44 3.33 
Intra-day precision (% relative standard deviation) (n=3) 1.9 2.3 
Inter-day precision (% relative standard deviation) (n=5) 3.4 3.3 
Amount (µg) 15.26 13.87 
Intra-day precision (% relative standard deviation) (n=4) 1.8 2.0 
Inter-day precision (% relative standard deviation) (n=5) 3.5 3.5 
 446 
Table 1: Intra-day and inter-day reproducibility of the chromatographic method for the detection 447 
of NAD and NADH in standard solutions at 260-nm absorbance. (Relative standard deviation is 448 
the standard deviation expressed as a percentage of the corresponding mean value.) 449 
 450 
451 
 19 
 451 
Standard contents % Recovered (SD) % Conversion (SD) % Total Recovered (SD) 
NAD (2.5 µg) 95.9 (4.9) None detected 95.9 (4.9) 
NADH (2.5 µg) 83.4 (6.6) 12.9 (6.2) 96.3 (2.1) 
 452 
Table 2: Percent recoveries obtained from the metabolite extraction protocol performed on 453 
standard solutions containing NAD or NADH. 12.9% of NADH was converted to NAD during 454 
sample processing. Values represent the mean and standard deviation of nine separate 455 
experiments. 456 
457 
 20 
 457 
Spike Contents % Recovered (SD) % Conversion (SD) % Total Recovered 
NAD (2.5 µg) 95. 6 (8.2) None detected  95. 6 (8.2) 
NAD (10 µg) 96.5 (6.0) None detected 96.5 (6.0) 
NADH (2.5 µg) 82.6 (12.3) 13.3 (11.3) 96.0 (9.2) 
NADH (10 µg) 83.2 (9.9) 12.0 (8.0) 95.2 (1.9) 
 458 
Table 3: Percent recoveries of authentic standard solutions of NAD or NADH spiked into 10 ml 459 
aliquots of yeast cultures grown in 20 g/L glucose immediately after pelleting the yeast for 460 
subsequent metabolite extraction. Each value represents the mean and standard deviation of at 461 
least three separate experiments performed on different days. 462 
 463 
 464 
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 Normal Calorie restriction 
 NAD NADH NAD/NADH Ratio 
NAD + 
NADH NAD NADH 
NAD/NADH 
Ratio 
 NAD + 
NADH 
Present study  97.30 (12.70) 
99.30 
(13.00) 
1.00 
(0.10) 
196.60 
(22.40) 
121.88 
(19.23) 
63.44 
(9.72) 
1.94 
(0.30) 
185.33 
(25.69) 
Lin et al.10  
(2004)a 
88.20 
(4.20) 
59.50 
(9.10) 1.48 147.70 
83.30 
(5.60) 
27.30 
(7.70) 3.05 110.60 
Anderson et al.3 
(2002)b 140 54 2.56 194 - - -  
Lin et al.11 
(2001)b 140 - 210 - -  140 – 210 - -  
Ashrafi et al.9 
(2000)b 79.80  -   -    -   -   -   
Smith et al.12 
(2000)b 149.80  -   -    -   -   -   
 465 
Table 4: Comparison of metabolite contents (amol/cell) of yeast grown under normal or calorie 466 
restriction conditions determined in this study and those obtained in prior studies via enzymatic 467 
assay. Data are presented as mean and standard deviation (SD) of replicates.  468 
aReported values10 have been converted from mM/cell to amol/cell assuming a yeast cell volume 469 
of 70 fL (10-15 L) and are expressed as the mean and standard deviation (SD) of 3 experiments 470 
performed in duplicate. 471 
bReported values3 were converted to mM/cell as reported10 and converted to amol/cell here 472 
assuming a yeast cell volume of 70 fL. 473 
474 
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Figure Captions 474 
 475 
Figure 1: Typical HPLC chromatograms of 10-µl aliquots of 50-mM ammonium acetate 476 
containing a) 2.50-µg NAD and b) 2.34-µg NADH (absorbance at 340 nm has been 477 
offset vertically by 10 mAu for clarity and an expanded view of the NADH peak is 478 
inset). Retention times (tr) of the authentic compounds are: NAD tr = 20.9 min., and 479 
NADH tr = 24.4 min.  480 
 481 
Figure 2: Standard curves for the chromatographic quantitation of authentic compounds of NAD 482 
and NADH. NAD contents range from 0.038 ng to 18.26 µg. NADH contents range 483 
from 0.068 ng to 13.87 µg. An expanded view of the standard curves near the origin 484 
is inset. Lines represent linear least squares fits to the data. Coefficients of correlation 485 
are 0.9975 for NAD and 0.9984 for NADH.  486 
 487 
Figure 3: Typical HPLC chromatogram of a 75-ul aliquot of yeast metabolite extracts from 488 
approximately 7 x 107 yeast cells grown in 20 g/L glucose. Retention times (tr) of the 489 
examined compounds are: NAD tr = 21.3 min., and NADH tr = 24.9 min.  490 
 491 
Figure 4: Metabolite contents (amol/cell) of yeast grown in synthetic complete media containing 492 
20 g/L glucose (normal) or 5 g/L glucose (calorie restriction). Data are presented as 493 
mean and standard deviation (SD) of seven separate experiments for each culture 494 
condition. Student’s t-test assessments were used to determine whether NAD, NADH 495 
and NAD+NADH are similar for the 20 and 5 g/L glucose growth conditions (* p < 496 
0.02, ** p > 0.10).  497 
498 
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Figures  498 
Figure 1:  499 
 500 
A) 501 
 502 
B)  503 
504 
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